[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both ...

The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses compared to teriflunomideIn a pivotal PPMS study ...
The Healthy @Reader's Digest on MSN

My Doctor Heard Something Strange in My Voice—Then Diagnosed Me with This Autoimmune Disease

One man shares how his life and work were upended before finally getting answers. Learn about new treatments are helping patients regain control and improve quality of life. Myasthenia gravis is ...

This Is The Most Commonly Missed Warning Sign Of Dementia

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

‘I thought my daughter had a migraine at new year – hours later, she collapsed and died’

There is a decline in infant and teenage vaccination rates which is leaving youngsters vulnerable to the disease, UKHSA warns ...